Epitope-Specific Anti-SerpinB3 Antibodies for SerpinB3 Recognition and Biological Activity Inhibition
暂无分享,去创建一个
P. Pontisso | S. Quarta | S. Ferro | O. Marin | M. Sandre | A. Biasiolo | G. Villano | M. Guido | C. Turato | M. Ruvoletto
[1] P. Pontisso,et al. Semisolid Wet Sol–Gel Silica/Hydroxypropyl Methyl Cellulose Formulation for Slow Release of Serpin B3 Promotes Wound Healing In Vivo , 2022, Pharmaceutics.
[2] Huange Zhu. Squamous Cell Carcinoma Antigen: Clinical Application and Research Status , 2022, Diagnostics.
[3] Bo Zhang,et al. PARG inhibition limits HCC progression and potentiates the efficacy of immune checkpoint therapy. , 2022, Journal of hepatology.
[4] Jennifer S. Yu,et al. SerpinB3 drives cancer stem cell survival in glioblastoma , 2021, bioRxiv.
[5] M. Fassan,et al. The protease‐inhibitor SerpinB3 as a critical modulator of the stem‐like subset in human cholangiocarcinoma , 2021, Liver international : official journal of the International Association for the Study of the Liver.
[6] Y. Geng,et al. Development of a nanobody-based immunoassay for the sensitive detection of fibrinogen-like protein 1 , 2021, Acta Pharmacologica Sinica.
[7] S. M. Toor,et al. Immune checkpoints in the tumor microenvironment. , 2020, Seminars in cancer biology.
[8] J. Marrero,et al. Biomarkers for the Early Detection of Hepatocellular Carcinoma , 2020, Cancer Epidemiology, Biomarkers & Prevention.
[9] R. Deshmukh,et al. Resistance to Checkpoint Inhibition in Cancer Immunotherapy , 2020, Translational oncology.
[10] M. Rugge,et al. Squamous cell carcinoma antigen 1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity , 2019, Cancer science.
[11] T. Nakano,et al. The clinical value of serum squamous cell carcinoma antigens 1 and 2 in head and neck squamous cell carcinoma. , 2019, Auris, nasus, larynx.
[12] G. Zhu,et al. Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3 , 2019, Cell.
[13] Lieping Chen,et al. A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization , 2018, Cell.
[14] Rongxin Zhang,et al. PD-1/PD-L1 pathway blockade works as an effective and practical therapy for cancer immunotherapy , 2018, Cancer biology & medicine.
[15] P. Pontisso,et al. SerpinB3 upregulates the Cyclooxygenase-2 / β-Catenin positive loop in colorectal cancer , 2017, Oncotarget.
[16] W. Zong,et al. SERPINB3 and B4: From biochemistry to biology. , 2017, Seminars in cell & developmental biology.
[17] M. Rugge,et al. Squamous cell carcinoma antigen (SCCA) is up-regulated during Barrett’s carcinogenesis and predicts esophageal adenocarcinoma resistance to neoadjuvant chemotherapy , 2016, Oncotarget.
[18] J. Wolchok,et al. Targeting T Cell Co-receptors for Cancer Therapy. , 2016, Immunity.
[19] P. Pontisso,et al. Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: A prospective study. , 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[20] Haixiang Yu,et al. Clinical significance of joint detection of serum CEA, SCCA, and bFGF in the diagnosis of lung cancer. , 2015, International journal of clinical and experimental pathology.
[21] G. Lippi,et al. Squamous cell carcinoma antigen in hepatocellular carcinoma: Ready for the prime time? , 2015, Clinica chimica acta; international journal of clinical chemistry.
[22] P. Pontisso,et al. SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity , 2015, Scientific Reports.
[23] X. Wang,et al. Current concepts of immune based treatments for patients with HCC: from basic science to novel treatment approaches , 2015, Gut.
[24] T. Yasui,et al. Prognostic significance of serum squamous cell carcinoma antigen in patients with head and neck cancer , 2015, Acta oto-laryngologica.
[25] Shi-ling Li,et al. Overexpression of squamous cell carcinoma antigen 1 is associated with the onset and progression of human hepatocellular carcinoma. , 2015, Archives of medical research.
[26] W. Zong,et al. SCCA1/SERPINB3 promotes oncogenesis and epithelial-mesenchymal transition via the unfolded protein response and IL6 signaling. , 2014, Cancer research.
[27] G. Giannelli,et al. Moving towards personalised therapy in patients with hepatocellular carcinoma: the role of the microenvironment , 2014, Gut.
[28] P. Pontisso,et al. SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis , 2014, British Journal of Cancer.
[29] W. Zong,et al. Oncogenic Ras induces inflammatory cytokine production by up-regulating the squamous cell carcinoma antigens SerpinB3/B4 , 2014, Nature Communications.
[30] P. Pontisso,et al. SERPINB3 protects from oxidative damage by chemotherapeutics through inhibition of mitochondrial respiratory complex I , 2013, Oncotarget.
[31] P. Pontisso,et al. IgM-Linked SerpinB3 and SerpinB4 in Sera of Patients with Chronic Liver Disease , 2012, PloS one.
[32] W. Zong,et al. Squamous Cell Carcinoma Antigen 1 Promotes Caspase-8-Mediated Apoptosis in Response to Endoplasmic Reticulum Stress While Inhibiting Necrosis Induced by Lysosomal Injury , 2011, Molecular and Cellular Biology.
[33] W. Zong,et al. Elevated Expression of Squamous Cell Carcinoma Antigen (SCCA) Is Associated with Human Breast Carcinoma , 2011, PloS one.
[34] P. Pontisso,et al. Increased antiprotease activity of the SERPINB3 polymorphic variant SCCA-PD , 2011, Experimental biology and medicine.
[35] P. Pontisso,et al. SERPINB3 induces epithelial–mesenchymal transition , 2009, The Journal of pathology.
[36] G. Fields,et al. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. , 2009, International journal of peptide and protein research.
[37] K. Izuhara,et al. Recent progress in understanding the diversity of the human ov-serpin/clade B serpin family , 2008, Cellular and Molecular Life Sciences.
[38] T. Oshikiri,et al. Transcriptional targeting of adenovirus vectors with the squamous cell carcinoma-specific antigen-2 promoter for selective apoptosis induction in lung cancer , 2006, Cancer Gene Therapy.
[39] Y-F Chen,et al. Increased expression level of squamous cell carcinoma antigen 2 and 1 ratio is associated with poor prognosis in early-stage uterine cervical cancer , 2006, International Journal of Gynecologic Cancer.
[40] K. Kadoya,et al. Serpin squamous cell carcinoma antigen inhibits UV-induced apoptosis via suppression of c-JUN NH2-terminal kinase , 2006, The Journal of cell biology.
[41] P. Pontisso,et al. Squamous cell carcinoma antigen‐immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma , 2005, Cancer.
[42] K. Dewar,et al. Comparative genomic analysis of the clade B serpin cluster at human chromosome 18q21: amplification within the mouse squamous cell carcinoma antigen gene locus. , 2004, Genomics.
[43] P. Pontisso,et al. Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma , 2004, British Journal of Cancer.
[44] J. Whisstock,et al. Human clade B serpins (ov-serpins) belong to a cohort of evolutionarily dispersed intracellular proteinase inhibitor clades that protect cells from promiscuous proteolysis , 2004, Cellular and Molecular Life Sciences CMLS.
[45] P. Gettins. Serpin structure, mechanism, and function. , 2002, Chemical reviews.
[46] J. Whisstock,et al. The serpin SQN-5 is a dual mechanistic-class inhibitor of serine and cysteine proteinases. , 2002, Biochemistry.
[47] J. Whisstock,et al. The Serpins Are an Expanding Superfamily of Structurally Similar but Functionally Diverse Proteins , 2001, The Journal of Biological Chemistry.
[48] L. A. Carpino,et al. The 5,6- and 4,5-benzo derivatives of 1-hydroxy-7-azabenzotriazole. , 2001, Organic letters.
[49] H. Hirakawa,et al. Squamous cell carcinoma antigen suppresses radiation-induced cell death , 2001, British Journal of Cancer.
[50] S. Pomeroy,et al. Circulating serpin tumor markers SCCA1 and SCCA2 are not actively secreted but reside in the cytosol of squamous carcinoma cells , 2000, International journal of cancer.
[51] M. Upton,et al. Co-expression of the Squamous Cell Carcinoma Antigens 1 and 2 in Normal Adult Human Tissues and Squamous Cell Carcinomas , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[52] H. Kato,et al. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma , 1977, Cancer.
[53] I. Benhar,et al. Novel immune check point inhibiting antibodies in cancer therapy-Opportunities and challenges. , 2017, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[54] Shalini Gupta,et al. Antibody Production with Synthetic Peptides. , 2016, Methods in molecular biology.
[55] P. Pontisso,et al. SERPINB3 (serpin peptidase inhibitor, clade B (ovalbumin), member 3). , 2015, Atlas of genetics and cytogenetics in oncology and haematology.
[56] F. Wang,et al. Squamous cell carcinoma antigen 1 and 2 mRNA and a new variant expressed in hepatocellular carcinoma. , 2014, Neoplasma.
[57] D. Hancock,et al. Synthetic peptides as antigens for antibody production. , 2005, Methods in molecular biology.